Lv21
165 积分 2025-07-22 加入
Qualitative and Psychometric Evaluation of 29-Item Patient-Reported Outcomes Measurement Information System® to Assess General Health-Related Quality of Life in Patients With Moderately to Severely Active Inflammatory Bowel Disease
9天前
已完结
Multidimensional Patient-Reported Outcomes and Quality of Life at Diagnosis of IBD: A Population-Based Inception Cohort Study
14天前
已完结
International expert guidance for defining and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound: a consensus statement
1个月前
已完结
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
1个月前
已完结
Early Biological Therapy Within 12 Months of Diagnosis Leads to Higher Transmural Healing Rates in Crohn's Disease
1个月前
已完结
Different levels of healing in inflammatory bowel diseases: mucosal, histological, transmural, barrier and complete healing
1个月前
已完结
Safety considerations with biologics and new inflammatory bowel disease therapies
1个月前
已完结
Su1895: CD64 BINDING IS UNLIKELY TO CONTRIBUTE TO THE CLINICAL EFFICACY OF IL-23 INHIBITORS IN IBD
1个月前
已完结
CD64 BINDING IS UNLIKELY TO CONTRIBUTE TO THE CLINICAL EFFICACY OF IL-23 INHIBITORS IN IBD
1个月前
已关闭
Differentiating IL-23 inhibitors in crohn's disease
2个月前
已完结
皖公网安备34019202002308
